Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 215Unknown 74Terminated 68Recruiting 64Active not recruiting 29Withdrawn 15Not yet recruiting 14Suspended 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2

Interventions

Gemcitabine 6Oxaliplatin 5Irinotecan 5Specimen Handling 4S 1 (combination) 4Leucovorin 4Fluorouracil 4Capecitabine 4Radiotherapy 3Nivolumab 3Drug Therapy 3Bevacizumab 3trifluridine tipiracil drug combination 2titanium silicide 2spartalizumab 2lenvatinib 2aldesleukin 2Surgical Procedures, Operative 2Photochemotherapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Immunotherapy 2Endoscopic Mucosal Resection 2Cyclophosphamide 2Cetuximab 2Biopsy 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zimberelimab 1vactosertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Cetuximab × Gastrointestinal × Clear all
NCT06102902 2026-05-13

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05200442 2026-05-08

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

University of Chicago

Phase 1/2 Suspended
53 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡